Device Trial Radar · NCT04801719
Endoluminal Radiofrequency Ablation for the Treatment of Malignant Biliary Stenosis
Last checked: Nov 19, 2026Latest source record: Mar 17, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
76
Actual
Start
Jan 4, 2010
Primary completion
Dec 31, 2019
Study completion Dec 31, 2019
Sponsor
- Lead sponsor
- Brno University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 17, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The rationale of the study is to explore the safety and efficacy of endoluminal radiofrequency ablation prior metal stent insertion in patiens with malignant biliary stenosis.
Conditions
- Radiofrequency Ablation
- Biliary Tract Cancer
- Stent Complication
- Brachytherapy
Interventions
Habib™ EndoHPB; Boston Scientific, US; former EMcision Ltd., UKDevice
Randomised patients in selected arm received endoluminal RFA by 8F catheter (Habib™ EndoHPB; Boston Scientific, US; former EMcision Ltd., UK) before stenting procedure. Repeated ablations were processed through stenotic areas of bile ducts (10W, 90-120s, Rita 1500, Angiodynamics Ltd), all drained biliary tracts were used for introducing catheter and performance of ablation. Ablation procedure was followed with uncovered self-expandable metal stent insertion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Stent patencyTime frame: up to month 36 or death of the patient
- Overall survivalTime frame: up to month 36 or death of the patient
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Brno University Hospital
Brno, Czechia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.